Cargando…

A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities

Vascular endothelial growth factor receptor 2 (VEGFR2) mediates VEGFA signaling mainly through the PI3K/AKT/mTOR and PLCγ/ERK1/2 pathways. Here we unveil a peptidomimetic (VGB3) based on the interaction between VEGFB and VEGFR1 that unexpectedly binds and neutralizes VEGFR2. Investigation of the cyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namjoo, Mohadeseh, Ghafouri, Hossein, Assareh, Elham, Aref, Amir Reza, Mostafavi, Ebrahim, Hamrahi Mohsen, Ali, Balalaie, Saeed, Broussy, Sylvain, Asghari, S. Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305181/ https://www.ncbi.nlm.nih.gov/pubmed/37375853 http://dx.doi.org/10.3390/ph16060906

Ejemplares similares

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2020)

Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1
por: Luo, Xu, et al.
Publicado: (2022)

Knockdown of VEGFB/VEGFR1 Signaling Promotes White Adipose Tissue Browning and Skeletal Muscle Development
por: Ling, Mingfa, et al.
Publicado: (2022)

Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity
por: Zanjanchi, Pegah, et al.
Publicado: (2022)

VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway
por: Ling, Mingfa, et al.
Publicado: (2021)

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Ye, Xiaoqing, et al.
Publicado: (2021)

Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway
por: Li, Rongrong, et al.
Publicado: (2022)

Structural Studies on an Anti-Angiogenic Peptide Using Molecular Modeling
por: Assareh, Elham, et al.
Publicado: (2020)

Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms
por: Akrami, Mohammad, et al.
Publicado: (2016)

Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine
por: Zhang, Cheng, et al.
Publicado: (2018)

A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics
por: Assareh, Elham, et al.
Publicado: (2023)

VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways
por: Weddell, Jared C., et al.
Publicado: (2017)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study
por: Abuzenadah, Adel M., et al.
Publicado: (2022)

Antiangiogenic Effect of Ethanol Extract of Vigna angularis via Inhibition of Phosphorylation of VEGFR2, Erk, and Akt
por: Kwon, Oh Sung, et al.
Publicado: (2015)

Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT/FAK signal axis
por: Wang, Xinzhi, et al.
Publicado: (2017)

Antiproliferative and Antiangiogenic Properties of New VEGFR-2-targeting 2-thioxobenzo[g]quinazoline Derivatives (In Vitro)
por: Abuelizz, Hatem A., et al.
Publicado: (2020)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists
por: Wang, Lei, et al.
Publicado: (2014)

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src
por: Sjöberg, Elin, et al.
Publicado: (2023)

Medicinal Plants Extracts with Antiangiogenic Activity: Where Is the Link?
por: Hoseinkhani, Zohreh, et al.
Publicado: (2020)

A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
por: Farzaneh Behelgardi, Maryam, et al.
Publicado: (2018)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Functional evaluation of a novel kisspeptin analogue on the reproduction of female goldfish
por: Rabouti, Hanieh, et al.
Publicado: (2022)

Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
por: Elmeligie, Salwa, et al.
Publicado: (2019)

Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB
por: Boer, Karin, et al.
Publicado: (2008)

Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase
por: Sohbati, Hamidreza, et al.
Publicado: (2022)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Promising Antibiofilm Activity of Peptidomimetics
por: Gomes Von Borowski, Rafael, et al.
Publicado: (2018)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Cell-free Biosynthesis of Peptidomimetics
por: Lee, Kanghun, et al.
Publicado: (2023)

Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy
por: Rojas, Juan D., et al.
Publicado: (2018)

Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds
por: Ebrahim, Hassan Y., et al.
Publicado: (2016)

Curso PLC y programación : todo sobre PLC /
por: Bustamante, José

Porvair plc, UK
Publicado: (2020)

Structure Based Antibody-Like Peptidomimetics
por: Murali, Ramachandran, et al.
Publicado: (2012)

Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis (†)
por: Cerminara, Iole, et al.
Publicado: (2012)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n1givvfr59m219rddsg8nb5bts